Experimental therapeutic cancer vaccine leads to significant tumor regression in mice

An experimental therapeutic cancer vaccine induced two distinct and desirable immune system responses that led to significant tumor regression in mice, report investigators from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

Related Keywords

National Institutes Of Health ,Maryland ,United States ,Baltimore ,Robert Seder ,Emily Henderson ,Vaccine Research Center ,National Institute Of Allergy ,Lab Diagnostics Automation ,Lab Diagnostics Automation Industry ,National Institute ,Infectious Diseases ,National Institutes ,Automation Industry Focus ,Research Center ,Vaccitech North America ,Cancer ,Vaccine ,Allergy ,Fell ,Immune Response ,Immune System ,Interferon ,Medical Research ,Research ,T Cell ,Humor ,